1 / 56

Hypoglycemia of Newborn

Hypoglycemia of Newborn. Dr. Ilya Rozin. הצגת מקרה. תאומים, בן ובת, נולדו לאם בת 30 בהריונה הראשון ( IVF ). מעקב הריון תקין. אם אושפזה בשבוע 32 עקב יתר לחץ-דם. מספר שעות טרם הלידה היתה ירידת מים. ילדה בניתוח קיסרי. הבת, מצג ראש, משקל לידה 1825 גרם, אפגר 8 ו-9, נזקקה למעט חמצן.

lindsay
Download Presentation

Hypoglycemia of Newborn

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hypoglycemia of Newborn Dr. Ilya Rozin

  2. הצגת מקרה • תאומים, בן ובת, נולדו לאם בת 30 בהריונה הראשון (IVF ). • מעקב הריון תקין. • אם אושפזה בשבוע 32 עקב יתר לחץ-דם. מספר שעות טרם הלידה היתה ירידת מים. ילדה בניתוח קיסרי. • הבת, מצג ראש, משקל לידה1825 גרם, אפגר 8 ו-9, נזקקה למעט חמצן. • סבלה מ-RDS , אינטובציה כשעה לאחר הלידה, קיבלה סורפקטנט, הונשמה למשך יממה.

  3. הצגת מקרה • הבן, מצג ראש, משקל 1600 גרם, אפגר 9 ו-10. • החל לקבל כלכלה (חלב אם) ביום השני לחיים. • ביממה הרביעית היו ערכי גלוקוז גבוהים בסטיק. • בדיקה גופנית – תקינה, בדיקות דם – תקינות, תרביות דם עקרות. • עקב היפרגליקמיה עקשנית הוחל במתן אינסולין, למרות זאת ערכי גלוקוז המשיכו להיות גבוהים. • ביממה הששית התינוק נראה חולה מאוד והחל לפרכס. נעשה ברור זיהומי מלא – שלילי. • ב-CSF גלוקוז12מג%, בסטיק בדם – 234 מג%, גלוקוז במעבדה 39 מג%.

  4. הצגת מקרה • הבת החלה לקבל חלב אם ביום השלישי לחיים. • ביממה החמישית הופיעו ערכי סוכר גבוהים בסטיק. • בהדרגה נראתה פחות טוב: חוורת, אפטית, ירדה 13% ממשקל לידה. • קיבלה עירוי של גלוקוז בריכוז נמוך עם אינסולין. עקב החמרה כללית במצב ואפנאות הונשמה. • נעשה ברור זיהומי – שלילי. • ב-CSFסוכר 1 מג%, גלוקוז בדם בסטיק 196 מג%, גלוקוז במעבדה – 14 מג%.

  5. הצגת מקרה • פער בין בדיקת הסוכר במעבדה ובסטיק. • הסטיק בודק חומרים מחזרים ולא גלוקוז בלבד. • נשלח דם ל- Galactose 1-Phosphate Uridyltransferase ונמצאה פעילות נמוכה מאוד של האנזים. • אבחנה: Classical Galactosemia

  6. הצגת מקרה • הוחל במתן גלוקוז בריכוזים עולים, • הופסק אינסולין, בהמשך קבלו כלכלה נטולת galactose. • US מוח ביום השני לחיים לשניהם תקין. • US מוח בשחרור: אזורים אקוגנים סביב החדרים עם ציסטות דו צדדיות. • במעקב: בעיות טונוס קשות, תנועות עיניים אבנורמליות, פיגור קוגניטיבי, CP.

  7. HYPOGLYCEMIA IN THE NEWBORN INFANT • Glucose metabolism in the fetus • Glucose metabolism in the neonate • Definition of hypoglycemia in the newborn • Etiology and types of hypoglycemia • Clinical presentation of hypoglycemia • Infant of diabetic mother • Management and outcome

  8. Glucose metabolism in the fetus • Maternal glucose is the major substrate delivered to the human fetus for energy metabolism. • Fetal uptake of glucose is regulated by maternal glucose concentration. • Glucose transport: concentration gradient – facilitated diffusion. • Fetal plasma glucose is ~ 70%-80% of mother’s. • When gestational age increases, uterine blood flow increases, therefore, blood flow to the fetus increases. • Glucose transport to the fetus is only 40-50%of the totaluptake by the placenta.

  9. Glucose metabolism in the fetus • Insulin in the 8 weeks of gestation and in 13-18 weeks fetal Insulin response to maternal hyperglycemia. Insulin: stimulates glucose incorporation into liver glycogen, acts as growth hormone • Growth Hormone in the 9 weeks and rapidly increased between 11-16 weeks of gestation. Fetal GH level is high to maternal plasma.

  10. Glucose metabolism in the fetus • Hepatic glycogen content is low in early gestation and increases slowly ( between 15-20 weeks of gestation). • Glycogenolysis and glycogenesis enzymes are present and increase slowly through pregnancy. • Absence of gluconeogenesis (gluconeogenesis enzymes are not active in utero). • 80% of fetal glucose to energy • 20% of fetal glucose to lactate, amino acid and other means.

  11. Glucose metabolism in the newborn:At birth… • Discontinuation of maternal substrates and nutrient supply: need to mobilize glucose or other substrates to meet energy requirements. • Glucose falls (nadir ~ 1-2 hours of age) and rises by 2-4 hours in all infants. • Glucoregulatory hormones (epinephrine, norepinephrine, glucagon) rise rapidly, insulin decreases (mobilization of glycogen and fatty acids).

  12. Levels of hormones and metabolic fuels change after birth

  13. Glucose metabolism in the newborn • Breast milk provides lactose but not more than 50% of glucose utilization rate. • Therefore, neonates are markedly dependent on active gluconeogenesis to maintain hepatic glucose production. • Role of elevated Growth Hormone is not defined. In first 48-72 hours level is low with elevation in the 8 weeks after birth.

  14. Glucose kinetics in the newborn • Rates of glucose production and utilization in the newborn are between 4-6 mg/kg/min • Rates are higher in the newborn compared with adults due to:- Higher metabolic rate- Higher brain-to-body weight ratio of the newborn brain • After 2 days, with the introduction of feeding, the normal infant maintains plasma glucose at 40-70 mg/dl (2.5-6 mmol /L).

  15. Definition of neonatal hypoglycemia • Statistical approach. • Clinical approach(Most infants recover after birth, lack of correlation with CNS side effects, lack of outcome studies, studies based on different populations, changes in mothers’ and infants’ care). • Most investigators would consider serum glucose concentration < 2.5 mmol/L or 45 mg/dl to be low in the first 72 hours of life. • The definition is the same for term and preterm infants. • Differ totransient and persistent ,symptomatic and asymptomatic hypoglycemia.

  16. Etiology of neonatal hypoglycemia I. TRANSIENT HYPOGLYCEMIAA. Changes in maternal metabolism: 1. Intrapartum administration of glucose 2. Drugs: terbutalin, ritodrin, propranolol 3. Diabetes in pregnancy (IDM)B. Neonatal problems: 1. IUGR/SGA infant 5. Preterm infant 2. Birth asphyxia 6. Rh-incompatibility 3. Infection 7. Hyperviscosity 4. Hypothermia 8. Cardiac malformations 9. Iatrogenic causes

  17. II. Persistent or recurrent hypoglycemia A. Hyperinsulinism:1. Beta-cell hyperplasia: nesidioblastosis -adenoma spectrum, sulfonylurea receptor defect. 2. Beckwith- Wiedemann Syndrome. B.Endocrine disorders:1. Pituitary insufficiency.2. Cortisol deficiency.3. Congenital glucagon deficiency. 4. Epinephrine deficiency. C. Inborn errors of metabolism:1. Carbohydrate metabolism – galactosemia, fructose intolerance, glycogen storage disease, gluconeogenesis disorders.2. Amino-acid metabolism – Maple-syrup urine disease, aminoacidopathies3. Fatty-acid metabolism – carnitine defects, acyl-CoA dehydrogenase defects. D. Nerohypoglycemia (hypoglycorrhahia): defective glucose transport.

  18. Beckwith’s syndrome with glossoptosis

  19. Incidence of hypoglycemia according to birth weight and gestational age

  20. Symptoms and signs of neonatal hypoglycemia • Abnormal cry • Apnea, cyanosis • Feeding difficulties • Respiratory distress • Hypothermia • Hypotonia • Irritability • Jitteriness, tremor • Lethargy, stupor • Seizures • Sweating • Tachycardia

  21. Infants of Diabetic Mothers Macrosomy, visceromegaly, unexplained fetal demise • congenital anomalies:Cardiac – VSD, TGA, TOF, double-outlet..Skeletal and CNS – caudal regressionGastrointestinal – small left colon • organs and systems abnormalities:HypoglycemiaHeart failure, septal hypertrophyPolycythemiaHyperbilirubinemiaHypocalcemiaRenal vein thrombosis

  22. Infants of Diabetic Mothers

  23. Maternal hyperglycemia Fetal hyperglycemia Fetal Hyperinsulinism Increased fetal substrate uptake Activity hepatic enzymes Metabolic rate Suppressed production of surfactant Lipid synthesis Oxygen consumption RDS Macrosomia Hypoxemia Cardiomegaly Synthesis of erythropoietin Adipose tissue Stillbirth? RBC mass - polycythemia

  24. Blood-work in neonatal hypoglycemia • Free fatty acid • Amino acids • Acetoacetate/beta hydroxybutirate • Urine: Ketones, organic acids, reducing substances • TSH • Glucose to lab (ASAP, on ice) • Electrolytes +chloride • Cortisol, growth hormone • Insulin level • Blood gases • Lactate + pyruvate • Ammonia

  25. Management of neonatal hypoglycemia • Anticipation in the high-risk group:LGA/SGA infants, IDM, acutely ill neonates, preterm infant, weight <2500 or > 4000 gr. • Treatment: transient vs. persistent symptomatic vs. asymptomatic • Investigation and treatment of the underlying cause

  26. Management of neonatal hypoglycemia I. TRANSIENT HYPOGLYCEMIA: Most are early, Asymptomatic and will recover with early feeding Symptomatic Hypoglycemia: • Bolus of 2 ml/kg glucose 10%. If seizure 4 ml/kg of glucose 10%. • All infants, irrespective of cause and age should be treated with parenteral glucose infusion: 6-8 mg/kg/min of dextrose 10%. • THE AIM: To maintain serum glucose above 45 mg/dl. Therefore: Glucose should be monitored frequently No response: Bolus of 2 ml/kg glucose 10% Increase rate or concentration. When blood glucose is stable for 4-6 hours feeding can be initiated and infusion can be weaned.

  27. Management of neonatal hypoglycemia • Persistent hypoglycemia glucose infusion rate > 12 mg/kg/min • Consider a diagnosis of hyperinsulinism, hormonal or metabolic disorders. • Add other drugs: - Hydrocortisone - Glucagon - Diazoxide - Somatostatin - Octreotide • Pancreatectomy

  28. Prognosis and outcome in neonatal hypoglycemia • Even asymptomatic hypoglycemia in healthy full term infants can be associated with abnormal neurologic exam (VEP). • Preterm infants have lower IQ results when exposed to recurrent hypoglycemia. They may be asymptomatic for long periods and need to be monitored. • IDM with hypoglycemia in the past, suffer lower school achievements compared with healthy newborns • Attention should be put when dealing with early discharge. • Brain MRI’S: damage of posterior hemispheres (occipital and parietal).

  29. Polycythemia • Hematocrit greatly exceeds normal values for gestational and postnatal age. • Affects approximately 1% to 5% of newborns. • Many affected infants are asymptomatic. • Mean Ht and Hb from capillary samples at birth are 61% +/- 7.4 and 19.3 g/dl +/- 2.2. • The diagnosis is based upon peripheral venous samples.

  30. Polycythemia • Polycythemia must be distinguished from hyperviscosity: if greater than 12 centipoise, measured at shear rate of 11.5 per sec ( 6 centipoise at rate of 106 per sec). • Viscosity and Ht have linear relationship when Ht is less than 60%. • Hyperviscosity occurred in only 47% of infant with polycythemia.

  31. Polycythemia Incidence • 1%-5% of healthy newborns screened. • Factors of influence the Ht during the first day after birth: - time delay between birth and clamping of the umbilical cord, - site of blood sampling, - age of the time sampling, - method of Ht measurement.

  32. Polycythemia Pathophysiology Hyperviscosity Reduced blood flow to organ Poor tissue perfusion

  33. Polycythemia Causes Two major mechanism: - active ( increased intrauterine erythropoesis) - passive ( erythrocyte transfusion )

  34. Polycythemia Causes Passive: • Daley clamping of the umbilical cord – most common. • Intrapartum hypoxia (increased placental transfusion). • Twin-to-twin transfusion (10%-15% of monochorionic twin). • Maternal-fetal transfusion.

  35. Polycythemia Causes Active: • Chronic intrauterine hypoxia and placental insufficiency: - SGA. - maternal preeclampsia or other vascular disorder. - maternal hypoxemia due to cardiac or pulmonary disorders. - drugs – propranolol. - smoking, high altitude, postterm date. - diabetic mother, LGA, Beckwith-Wiedemann syndrome. • Endocrine abnormalities: congenital adrenal hyperplasia, hypothyroidism, hyperthyroidism. • Chromosomal abnormalities: trisomy 21,18,13.

  36. Polycythemia Clinical features • Often begin by two hours after birth. • May delayed to the 2-3 day because of excessive extracellular fluid loss. • Infants with no symptoms by 48 to 72 hours of age are likely to remain asymptomatic. • Signs and symptoms usually due to reduced tissue perfusion or associated metabolic abnormalities.

  37. Polycythemia - Clinical features • CVS & Respiratory:- acrocyanosis and sluggish peripheral perfusion, - plethora, - cyanosis (17%), - tachypnea & distress, - heart murmur, heart failure and increased vascular resistance.

  38. Polycythemia - Clinical features • Neurologic effects:- irritability, - abnormal cry, - jitteriness, - lethargy, - hypotonia, - apnea. (associated with reduce cerebral blood flow)

  39. Polycythemia - Clinical features • Gastrointestinal disorder: - abdominal distention, - poor feeding. - NEC ( sometimes). ( in 20% of affected infants).

  40. Polycythemia - Clinical features • Genitourinary:-hematuria, proteinuria, RVT. • Hypoglycemia:- common, in 14%-40%, - Increased Gluc. utilization. • Hyperbilirubinemia:-in 1/3 of infants, -breakdown and increased number of circulated RBC. • Thrombocytopenia:- one report ( 6 of 32 ) - if Ht > 70% - Plt. <100.K

  41. Polycythemia Diagnosis • Should be in infant who appear plethoric or who have signs or symptoms my be due to polycythemia. • Ht on a capillary blood sample from a wormed heel. • If Ht capillary > 65% - repeat on a venous blood. • Diagnosis of polycythemia if the venous Ht is > 65%.

  42. Management of polycythemia • Controversial – uncertain whether intervention affect long-term outcome, may be associated with some GIT morbidity. • Asymptomatic newborn with polycythemia do not appear to benefit from treatment. • All polycythemic infant should be monitoring to hypoglycemia and hyperbilirubinemia.

More Related